CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.810
+0.010 (0.36%)
At close: Aug 5, 2026, 4:00 PM EDT
2.790
-0.020 (-0.71%)
After-hours: Aug 5, 2026, 5:57 PM EDT

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
387320431032
Market Cap Growth
-53.19%258.94%-52.96%319.53%-67.33%-38.31%
Enterprise Value
24.9552.23-18.5635.5-12.2-5.72
Last Close Price
2.817.902.347.637.5923.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.1318.242.096.06--
PB Ratio
2.444.010.525.870.510.90
P/TBV Ratio
2.453.920.482.750.200.48

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.9413.04-1.914.97--
EV/EBITDA Ratio
--1.02-3.510.23
EV/EBIT Ratio
--1.02-3.510.23
EV/FCF Ratio
--1.12-4.740.39

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.22-1.14-0.99-1.06-1.11-1.07
Net Debt / EBITDA Ratio
0.420.742.131.006.481.52
Net Debt / FCF Ratio
0.470.892.361.058.752.57
Asset Turnover
0.110.120.370.4400
Quick Ratio
2.874.5710.613.359.3212.75
Current Ratio
3.364.9111.113.849.3612.92
Return on Equity (ROE)
-208.31%-93.92%-69.95%-15.74%-21.05%-80.69%
Return on Assets (ROA)
-163.73%-85.79%-68.71%-47.92%-11.49%-73.91%
Return on Invested Capital (ROIC)
------1197.86%
Return on Capital Employed (ROCE)
-215.70%-98.55%-78.26%-56.63%-12.61%-81.98%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-5.45%-12.00%-203.34%-413.65%27.81%0.00%
Total Shareholder Return
-5.45%-12.00%-203.34%-413.65%27.81%0.00%
SEC Filings: 10-K · 10-Q